Intracellular metabolism of amyloid β-protein precursor (APP) is important for the pathogenesis of Alzheimer's disease (AD). Alcadeins (Alcα, Alcβ, and Alcγ) are neural membrane proteins similar to APP in their localization, metabolism, and cellular function. Isoform ε4 of apolipoprotein E (ApoE) is major risk factor for AD. We found that ApoE expression attenuated intracellular trafficking of APP and Alcβ, resulting in metabolic stabilization of both proteins. By contrast, Alcα intracellular proteolysis was facilitated by ApoE expression, which was not due to an increase in the primary cleavage of Alcα. This difference may result from binding of ApoE to membrane proteins. small peptide generated by α-and γ-site cleavages of Alc; sAlc, amino-terminal extracellular domain fragments of Alc secreted by a cleavage of Alc by primary secretase; sAPP, amino-terminal extracellular domain fragments of APP secreted by cleavage of APP by primary secretases.
in a radioimmunoprecipitation assay (RIPA) buffer containing protease inhibitor cocktail. In order to analyze secreted proteins, FLAG-tagged sAlcα, sAlcβ, and sAPP were recovered from conditioned medium by immunoprecipitation with an anti-FLAG antibody and Protein G-Sepharose. Cell lysates and the immunoprecipitates were analyzed by Western blotting with the indicated antibodies, detected by ECL (GE Healthcare), and quantitated using VersaDoc Model 3000 (Bio-Rad Laboratries).
In co-immunoprecipitation assays, cells were lysed with CHAPS lysis buffer (10 mM CHAPS in PBS including a protease inhibitor cocktail). After centrifugation (15,000 × g for 10 min), the indicated antibodies and Protein G-Sepharose beads were added to the lysate supernatant and incubated for 8-12 h with agitation. The beads were recovered by centrifugation and washed with CHAPS lysis buffer, and the immunoprecipitates were analyzed by Western blotting using the indicated primary antibodies along with horseradish peroxidase (HRP)-linked anti-rabbit or anti-mouse IgG secondary antibody.
Cell-surface biotinylation
Cells were washed with ice-cold PBS and incubated with 0.5 mg/mL of NHS-LC-Biotin (Thermo Fisher Scientific) in PBS for 30 min at 4°C. The cells were further incubated with ice-cold 50 mM glycine in PBS for 5 min and washed with ice-cold PBS, and then subjected to lysis in RIPA buffer containing protease inhibitor cocktail. After centrifugation (15,000 × g for 10 min), NeutrAvidin agarose beads (Thermo Fisher Scientific) were added to the supernatant of the lysate and incubated for 2 h under rotation. The beads were recovered by centrifugation and washed with RIPA buffer, and the bound proteins were analyzed by Western blotting.
Antibodies
Monoclonal mouse anti-FLAG (M2, Sigma-Aldrich), anti-HA (12CA5, BD Biosciences) and anti-α-tubulin (DM1A, Santa Cruz Biotechnology) antibodies, and polyclonal rabbit anti-human ApoE (#18171, IBL), anti-APP C-terminal (#8717, Sigma-Aldrich) antibodies were purchased from the indicated suppliers. Polyclonal sheep anti-mouse IgG HRP-linked species-specific whole antibody (NA931) and donkey anti-rabbit IgG HRP-linked species-specific whole antibody (NA934) were purchased from GE Healthcare. Polyclonal rabbit anti-Alcadein α (#83) and anti-Alcadein β (#99) antibodies were described previously [6] .
Results

Stabilization of intracellular metabolism of APP and Alcβ, but not Alcα.
To investigate the basic intracellular metabolism of APP and major Alc species, Alcα and Alcβ, under the expression of ApoE, we performed a pulse-chase study in the presence or absence of ApoE4 expression ( Fig. 1) . N2a cells expressing APP, Alcα, and Alcβ with or without ApoE4 were cultured in the presence of cycloheximide, and cells were harvested at the indicated times for analysis of intracellular protein metabolism by Western blotting. Consistent with a previous report [26] , immature APP (imAPP) with N-glycosylation was subject to O-glycosylation during maturation in the late Golgi, and mature APP (mAPP) gradually disappeared as a result of cleavage by APP α-and/or β-secretases (Fig. 1A) . The half-life of total APP (mAPP plus imAPP) metabolism was 42.7 ± 3.8 min. In the presence of ApoE4, mAPP metabolism was not changed (i.e., the half-lives of mAPP in the presence or absence of ApoE4 were almost identical), whereas the imAPP level was not reduced. The observation indicates that ApoE4 expression suppressed APP maturation, which means that ApoE4 may attenuate the intracellular transport of APP into the late secretory pathway; consequently, the intracellular level of imAPP did not decrease. Therefore, the half-life of total APP metabolism was significantly stabilized (to 75.0 ± 9.6 min) in the presence of ApoE4, regardless of the invariant rates of mAPP metabolism.
This tendency was also observed for Alcβ (Fig. 1C) . The half-life of total Alcβ (both Alcβ with either complex or high-mannose N-glycans) was slightly extended (to 197.8 ± 37.3 min in the presence of ApoE4 from 136.4 ± 13.6 min in the absence of ApoE4, although this difference was not statistically significant at the time points studied. However, Alcβ with high-mannose N-glycan (hAlcβ) tended to exhibit a longer half-life and was statistically significant at 240 min in the presence of ApoE4, suggesting again that ApoE4 attenuates Alcβ intracellular transport by retaining hAlcβ for a longer time in the early secretory pathway, as in the case of imAPP. As for mAPP, the metabolism of Alcβ with complex N-glycan (cAlcβ) in the presence of ApoE was almost the same in the absence of ApoE.
In contrast to APP and Alcβ, the half-life of total Alcα was shortened to 44.3 ± 7.3 min in the presence of ApoE4 from 73.1 ± 14.0 in the absence of ApoE4 (Fig.   1B ). This change in the total amount of Alcα (i.e., Alcα with either complex or high-mannose N-glycans) was statistically significant at 30 and 60 min, indicating that metabolism of Alcα was facilitated in the presence of ApoE4. cAlcα and hAlcα also showed a shorter half-life, significantly at 30 and/or 60 min. Overall, intracellular metabolism Alcα, in contrast to that of Alcβ and APP, was facilitated or at least not delayed by co-expression of ApoE4. ApoE4 levels also decreased gradually along with chase time because cellular ApoE was secreted.
ApoE4 is the isoform associated with the greatest risk of AD onset, and it differs from ApoE2 and ApoE3 in various functions including Aβ metabolism [27, 28] . To reveal the effect of ApoE isoforms on the intracellular behavior of APP and Alc , we examined ApoE isoform-specific effects. In these experiments, APP or Alc was expressed in N2a cells with ApoE ε2, ε3, or ε4 isoforms, and changes of intracellular Alc and APP levels were examined by Western blotting (Fig. 2) . All ApoE isoforms decreased the intracellular Alcα level to the same extent statistically significantly, but had no effect on Alcβ and APP levels, indicating that the effect of ApoE on intracellular APP and Alc metabolism is isoform-independent. ApoE4 and ApoE3 protein expression levels were slightly lower than that of ApoE2, regardless of the almost equal levels of mRNA ( Fig. 2B and C) , possibly reflecting a difference in stability among ApoE isoforms in the cell. Hereafter, we used ApoE4 for further analysis.
Primary cleavage of APP and Alc is not altered by co-expression of ApoE
The results of the pulse-chase study suggested that ApoE expression does not alter the primary cleavages of APP and Alcs: the reductions in the levels of mAPP and cAlcs, which predominantly appear on the cell surface, were not remarkable in the presence of ApoE. However, in contrast to imAPP, which stays in the ER and early Golgi, hAlcs appeared at some level on the cell surface, where they were cleaved by α-secretase.
Therefore, a reduction in intracellular Alcα level may be caused by elevated primary cleavage of Alcα, but not APP or Alcβ. We investigated whether ApoE co-expression promoted the primary cleavage of APP and/or Alcs. Following primary cleavage, the amino-terminal regions of APP and Alcs are secreted as sAPP, sAlcα, and sAlcβ respectively, [7] . We investigated changes in primary cleavage in cells expressing APP, Alcα, or Alcβ, with or without co-expression of ApoE4 ( Fig. 3) . Medium of N2a cells expressing FLAG-tagged APP, Alcα, or Alcβ, together with or without ApoE4-HA, were subjected to immunoprecipitation with FLAG antibody and the immunoprecipitates were examined by Western blotting with the same antibody.
Notably, production of all three amino-terminal regions (sAPP, sAlcα, and sAlcβ) was decreased when ApoE4 was co-expressed ( Fig. 3A) : generation of sAPP and sAlcβ decreased by ~80%, whereas sAlcα secretion decreased by ~50%. The reductions in APP and Alcβ cleavage may be due to the slight decrease in cell-surface APP and Alcβ ( Fig. 3B) , which resulted in metabolic stabilization by ApoE expression ( Fig. 1) .
In contrast to APP and Alcβ, the cleavage of Alcα significantly decreased ( To confirm this finding, we introduced amino-acid substitutions around the primary cleavage site ( Fig. 4A) . When the resulting mutant, Alcα (HAmut), containing the HA-tag sequence instead of the α-cleavage sequence, was expressed in N2a cells, Alcα HAmut was remarkably stable with respect to primary cleavage. Large amounts of Alcα HAmut, especially cAlcα, were detected relative to Alcα in wild-type (WT) in cells without ApoE4 expression ( Fig. 4B, -) . By contrast, the intracellular levels of Alcα HAmut and WT were decreased by 30% upon co-expression of ApoE4. These data strongly indicate that the reduction in the level of Alcα in cells expressing ApoE is not due to an increase in primary cleavage. Furthermore, except for the primary cleavage, Alcα was subject to more intracellular degradation in the presence of ApoE.
Interactions of ApoE4 with APP and Alc.
ApoE and the extracellular/luminal region of APP and Alcs may face the lumen of organelles and transport vesicles in the secretory pathway. Hence, we asked whether intracellular ApoE can bind Alc or APP.
N2a cells expressing APP, Alcα, or Alcβ with ApoE4-FLAG were lysed, and co-immunoprecipitation assay was performed using the FLAG antibody (Fig. 5) . The antibody co-immunoprecipitated Alcβ with high-mannose N-glycan along with FLAG-ApoE4 ( Fig. 5C) , whereas FLAG-ApoE4 did not co-precipitate Alcα (Fig. 5B) .
The data show that ApoE4 associates with Alcβ in the ER or early Golgi, but not in the late secretory pathway. ApoE4 bound neither hAlcα nor cAlcα, indicating that Alcα and ApoE do not engage in intracellular interaction.
We examined intracellular localization of APP, Alcα or Alcβ in the presence or absence of ApoE4. N2a cells were transiently expressed with FLAG-tagged APP, Alcα and Alcβ in the presence or absence of ApoE4-EGFP expression, and subjected to immunostaing analysis with anti-FLAG and anti-EGFP antibodies. APP and Alcβ were strongly collocalized with ApoE4 in perinuclear Golgi-like structure (white color in merged panels), and the signals of APP and Alcβ in cytoplasmic region decreased when compared to these in cells without ApoE4 expression (magenta color in merge panels), while the localization of Alcα were largely independent of ApoE4 staining in Golgi and detectable in the cytoplasmic region even in the presence of ApoE4 (Supplementary   figure) . These observations support that ApoE4 associates to APP and Alcβ, but not to Alcα, to untransport APP and Alcβ in perinuclear early secretory compartment.
The interaction of hAlcβ with ApoE is consistent with the stabilized intracellular metabolism of hAlcβ, in contrast to that of cAlcβ ( Fig. 1) . Alcβ may include the ApoE-binding domain, and the complex N-glycan of Alcβ may inhibit ApoE binding.
ApoE4 weakly bound both mature and immature APP ( Fig. 5A) , consistent with reports that the Aβ sequence and amino-terminal ecto-domain of APP bind to ApoE [29, 30] .
Thus, it is conceivable that among APP, Alcα, and Alcβ, only Alcα cannot bind ApoE intracellularly, and that proteolysis of Alcα is facilitated en route to the cell surface [31].
Discussion
In this study, we investigated the effect of ApoE expression on the intracellular metabolism of APP and Alcs. We made several key observations: (i) APP metabolism [30] Hass S., Fresser F., Kochl S., Beyreuther K., Utermann G. and Baier G. 
